Dr. Kosj Yamoah, MD, PhD

Dr. Yamoah practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Yamoah's NPI, 1104106152, was assigned on August 23, 2011. Dr. Yamoah graduated from Icahn School Of Medicine At Mount Sinai in 2010. Dr. Yamoah holds Florida license ME124646.

Dr. Yamoah's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Yamoah's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Yamoah to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yamoah practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Yamoah's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Yamoah is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Yamoah's licenses on file in 3 states: Florida, Pennsylvania and Missouri.

Dmand AI lists bladder cancer radiation and prostate cancer radiation among the conditions Dr. Yamoah treats.

CMS data shows 226 Medicare services from Dr. Yamoah across 5 procedure codes in 2024, for 47 Medicare patients. Medicare paid $29,771 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Yamoah in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yamoah's median patient age at 70, with 2% women.

In 2023, Dr. Yamoah wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $157 in total drug cost. In 2022, CMS named 28 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Yamoah for performance year 2024, reported as part of a group. Dr. Yamoah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yamoah as offering telehealth.

Dmand AI links 108 papers to Dr. Yamoah, published from 2003 to 2025. 2021 was the busiest year, with 12. The most frequent topics are Prostatic Neoplasms, Black or African American and Prostate-Specific Antigen. Dr. Yamoah has published most often in Prostate Cancer Prostatic Dis. Dr. Yamoah's most frequent co-authors are Brandon Mahal, MD, Jasreman Dhillon, MD and Julio M. Pow-Sang, MD.

Dmand AI links Dr. Yamoah to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 3.

CMS Open Payments shows 32 general payments to Dr. Yamoah from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 39% of the total. Janssen Research & Development, LLC paid the most, $4,320.

Dr. Yamoah graduated from Icahn School Of Medicine At Mount Sinai in 2010. Dr. Yamoah is a member of ASTRO.

Dr. Yamoah is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.